Sarepta Therapeutics (SRPT) PT Raised to $207 at Credit Suisse; 'DMD Bull Thesis Strengthens Further'
Tweet Send to a Friend
(Updated - March 11, 2019 8:29 AM EDT)(updated to add analyst comments)Credit Suisse analyst Martin Auster raised his price target ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
